Orialpha (Oriplantee Company)

N/A

Report date: 2026/02/05 20:00:17

Base Information

Drug NameOrialpha (Oriplantee Company)
Drug Alias NameBD-C
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnam
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOriplantee Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOriplantee Company Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A